Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma - Lacouture ME; Davis ME; Elzinga G; Butowski N; Tran D; Villano JL; DiMeglio L; Davies AM; Wong ET (Seminars in Oncology, 2014)
FEMU ID: 30309; EMF-Portal URL: https://www.emf-portal.org/en/article/30309